Phase-I/II Study of Bortezomib in Combination with Carboplatin and Bevacizumab as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Phase-I/II Study of Bortezomib in Combination with Carboplatin and Bevacizumab as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer

Published:2012-06 Issue:6 Volume:7 Page:1032-1040
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Piperdi Bilal,Walsh William V.,Bradley Kendra,Zhou Zheng,Bathini Venu,Hanrahan-Boshes Meredith,Hutchinson Lloyd,Perez-Soler Roman

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference32 articles.

1. Cancer Statistics 2004 CA Cancer;Jemal;J Clin,2008

2. Chemotherapy in non-small cell lung cancer: a meta-analysis using data on individual patients from 52 randomized clinical trials;BMJ,1995

3. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer;Schiller;N Engl J Med,2002

4. Current standards of care in small-cell and non-small-cell lung cancer;Schiller;Oncology,2001

5. Investigator's Brochure Genentech. . Recombinant Humanized Monoclonal Anti-VEGF Antibody (rhuMAb VEGF, Bevacizumab) 2005

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellulose based molecularly imprinted polymer by hydroxyl functional allocation strategy with dual selectivity of boric acid affinity and molecular structure limitation to bortezomib: Preparation strategy, selectivity exploration, and metabolism study;Microchemical Journal;2024-10

2. Targeting metabolic pathways alleviates bortezomib-induced neuropathic pain without compromising anticancer efficacy in a sex-specific manner;Frontiers in Pain Research;2024-06-24

3. Proteasome inhibitors in the treatment of nonsmall cell lung cancer: A systematic review of clinical evidence;Health Science Reports;2023-11

4. Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells;Molecular and Cellular Biochemistry;2022-10-27

5. Smurf2 inhibition enhances chemotherapy and radiation sensitivity in non-small-cell lung cancer;Scientific Reports;2022-06-16